TherapeuticsMD, Inc. Common Stock (NASDAQ: TXMD) last traded at $1.97, up 0.51% on the session. The quote above updates while this page is open; the figures below are drawn from TherapeuticsMD, Inc. Common Stock’s own filings and are restated only when a new one is published.
TherapeuticsMD, Inc. Common Stock trades on NASDAQ under the ticker TXMD. Its market capitalisation is $22.80 million.
Valuation measures for TherapeuticsMD, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $22.80M |
|---|---|
| Enterprise value | $24.01M |
| Price / sales | 6.97 |
| Price / book | 0.84 |
| Beta | 0.18 |
Trailing-twelve-month figures tagged in TherapeuticsMD, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.27M |
|---|---|
| Net income (TTM) | -$217.0K |
| EPS (TTM) | -$0.0200 |
| Operating margin | -120.89% |
| Return on equity | -0.80% |
| Cash | $9.19M |
Range and volume for TXMD over the past 52 weeks.
| 52-week high | $2.95 |
|---|---|
| 52-week low | $1.03 |
| Volume | 6.9K |
| Average volume | 23.6K |
| Previous close | $1.96 |
Invest a chosen dollar amount in TherapeuticsMD, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TXMD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.